GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Promimic AB (OSTO:PRO) » Definitions » Cash-to-Debt

Promimic AB (OSTO:PRO) Cash-to-Debt : No Debt (1) (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Promimic AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Promimic AB's cash to debt ratio for the quarter that ended in Mar. 2024 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Promimic AB could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Promimic AB's Cash-to-Debt or its related term are showing as below:

OSTO:PRO' s Cash-to-Debt Range Over the Past 10 Years
Min: 3.69   Med: No Debt   Max: No Debt
Current: No Debt

During the past 5 years, Promimic AB's highest Cash to Debt Ratio was No Debt. The lowest was 3.69. And the median was No Debt.

OSTO:PRO's Cash-to-Debt is ranked better than
99.64% of 839 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs OSTO:PRO: No Debt

Promimic AB Cash-to-Debt Historical Data

The historical data trend for Promimic AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Promimic AB Cash-to-Debt Chart

Promimic AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
14.30 40.01 3.69 No Debt No Debt

Promimic AB Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison of Promimic AB's Cash-to-Debt

For the Medical Devices subindustry, Promimic AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promimic AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Promimic AB's Cash-to-Debt falls into.



Promimic AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Promimic AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Promimic AB had no debt (1).

Promimic AB's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Promimic AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Promimic AB  (OSTO:PRO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Promimic AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Promimic AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Promimic AB (OSTO:PRO) Business Description

Traded in Other Exchanges
Address
c/o AstraZeneca R&D Mölndal, AZ BioVentureHub, Molndal, SWE, 431 83
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.